Xeomin (Merz North America, Inc.)
Welcome to the PulseAid listing for the Xeomin drug offered from Merz North America, Inc.. This Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merz North America, Inc. |
| NON-PROPRIETARY NAME: | incobotulinumtoxinA |
| SUBSTANCE NAME: | BOTULINUM TOXIN TYPE A |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2011-08-01 |
| END MARKETING DATE: | 0000-00-00 |
Xeomin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xeomin from Merz North America, Inc. |
| LABELER NAME: | Merz North America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100([USP’U]/1) |
| START MARKETING DATE: | 2011-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 46783-160_d65a4ba1-cbc9-4159-bdda-983f4da7cddf |
| PRODUCT NDC: | 46783-160 |
| APPLICATION NUMBER: | BLA125360 |
Other BOTULINUM TOXIN TYPE A Pharmaceutical Manufacturers / Labelers:
